Panel Discussion: Accelerating OSD innovation: From R&D to market

Panellists in this video:
+ Dr Manikandan Ramalingam, Sr VP – Head Formulation R&D, Granules India (MODERATOR)
+ Dr Sajeev Chandran, VP-Pharmaceutical R&D, Lupin
+ Dr Manish Chawla, VP & Head (R&D), Lotus Pharmaceutical
+ Dr Sachin Arora, VP & Delivery Manager- Formulation Development Oral Solids – US, EU, CA & Global Markets, Dr Reddy’s Laboratories
+ Dr Sandhya Shenoy, AVP – Formulation R&D, MSN Laboratories
+ Dr Khalid Akhter Ansari, Senior Director, Technical Operations, Rising Pharmaceuticals

Key Highlights:
[1] Artificial intelligence is accelerating formulation development through rapid literature review, stability prediction, and excipient compatibility analysis.

[2] Cost, convenience and compliance should be considered while innovating oral dosage forms

[3] Efficient and effective of technology and structured data can improve drug efficacy and help reduce timelines from lab to market

[4] Computational modeling offers value but requires close collaboration between formulation scientists and data experts to ensure reliability.

[5] Digital tools and automation enhance quality systems by predicting impurities, controlling process deviations, and minimizing human error.

[6] Early engagement with regulatory authorities supports better alignment and faster development timelines.

[7] Developing the right talent and skill set is critical for successfully integrating digital and scientific approaches in formulation.